O’Shea, T., & Druce, M. (2017). When should genetic testing be performed in patients with neuroendocrine tumours? Rev Endocr Metab Disord.
Stile di citazione ChicagoO’Shea, Triona, e Maralyn Druce. "When Should Genetic Testing Be Performed in Patients With Neuroendocrine Tumours?" Rev Endocr Metab Disord 2017.
Citazione MLAO’Shea, Triona, e Maralyn Druce. "When Should Genetic Testing Be Performed in Patients With Neuroendocrine Tumours?" Rev Endocr Metab Disord 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.